Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Seminars in Cancer Biology|August 17, 1999
Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesisJ Breivik, G GaudernackTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 10, 1990
[Quality assurance of medical technical equipment]A Bedringås, O Baekken, R Karlsen, et al.British Journal of Cancer|February 1, 1994
K-ras mutation in colorectal cancer: relations to patient age, sex and tumour locationJ Breivik, G I Meling, A Spurkland, et al.International Journal of Cancer|January 2, 1994
p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp)B Fossum, T Gedde-Dahl, J Breivik, et al.International Journal of Cancer|January 8, 1998
Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factorsJ Breivik, R A Lothe, G I Meling, et al.Scandinavian Journal of Gastroenterology|January 1, 1997
K-ras mutations and prognosis in large-bowel carcinomasS N Andersen, T Løvig, J Breivik, et al.Military Medicine|November 17, 2016
Soldier Health Habits and the Metabolically Optimized BrainKarl E Friedl, Torbjorn J Breivik, Robert Carter, et al.Lancet (London, England)|November 25, 1995
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutationM K Gjertsen, A Bakka, J Breivik, et al.International Journal of Cancer|August 15, 1994
A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?B Fossum, J Breivik, G I Meling, et al.British Journal of Cancer|July 1, 1996
K-ras mutations and HLA-DR expression in large bowel adenomasS Norheim Andersen, J Breivik, T Løvig, et al.Pageof 2